S&P 500
(0.25%) 5 112.52 points
Dow Jones
(0.21%) 38 319 points
Nasdaq
(0.24%) 15 966 points
Oil
(-1.42%) $82.66
Gas
(3.85%) $1.997
Gold
(0.03%) $2 347.90
Silver
(0.01%) $27.54
Platinum
(3.53%) $954.65
USD/EUR
(-0.19%) $0.933
USD/NOK
(-0.34%) $10.99
USD/GBP
(-0.44%) $0.797
USD/RUB
(1.49%) $93.24

实时更新: First Trust Heitman [PRME]

交易所: NYSE 部门: Healthcare 工业: Biotechnology
BUY
100.00%
return 6.79%
SELL
50.00%
return 3.93%
最后更新时间29 Apr 2024 @ 23:06

8.02% $ 4.78

购买 107657 min ago

@ $6.86

发出时间: 15 Feb 2024 @ 04:49


回报率: -30.32%


上一信号: Feb 14 - 22:30


上一信号: 出售


回报率: 2.01 %

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 23:06):

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence...

Stats
今日成交量 362 026
平均成交量 727 290
市值 573.30M
EPS $0 ( 2024-03-14 )
下一个收益日期 ( $-0.470 ) 2024-05-09
Last Dividend $0.800 ( 2019-09-10 )
Next Dividend $0 ( N/A )
P/E -2.19
ATR14 $0.0250 (0.52%)
Insider Trading
Date Person Action Amount type
2024-02-29 Marrazzo Jeffrey D Buy 250 000 Stock Option (right to buy)
2024-02-20 Gv 2023 Gp, L.l.c. Buy 0 Common Stock
2024-02-25 Gottesdiener Keith Michael Buy 100 000 Stock Option (right to buy)
2024-02-21 Brudnick Richard Buy 135 747 Stock Option (right to buy)
2024-02-21 Duffield Jeremy Buy 180 995 Stock Option (right to buy)
INSIDER POWER
34.78
Last 97 transactions
Buy: 38 299 882 | Sell: 27 394 093

音量 相关性

長: -0.02 (neutral)
短: 0.11 (neutral)
Signal:(40.594) Neutral

First Trust Heitman 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

First Trust Heitman 相关性 - 货币/商品

The country flag -0.19
( neutral )
The country flag -0.09
( neutral )
The country flag 0.00
( neutral )
The country flag 0.09
( neutral )
The country flag 0.37
( neutral )
The country flag -0.57
( weak negative )

First Trust Heitman 财务报表

Annual 2023
营收: $0
毛利润: $-4.65M (0.00 %)
EPS: $-2.18
FY 2023
营收: $0
毛利润: $-4.65M (0.00 %)
EPS: $-2.18
FY 2022
营收: $5.21M
毛利润: $-6.80M (-130.60 %)
EPS: $-1.250
FY 2021
营收: $0.00
毛利润: $0.00 (0.00 %)
EPS: $-2.55

Financial Reports:

No articles found.

First Trust Heitman Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

First Trust Heitman Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A
Information
First Dividend $0.0900 2015-12-23
Last Dividend $0.800 2019-09-10
Next Dividend $0 N/A
Payout Date 2019-09-12
Next Payout Date N/A
# dividends 15 --
Total Paid Out $3.83 --
Avg. Dividend % Per Year 0.00% --
Score 1.65 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2024-05-21)
$0 Estimate 0.00 %
Dividend Stability
0.09 Very Bad
Dividend Score
1.65
Pay Frequency
Quarterly
Yearly Payout
Year Amount Yield
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Top 10 dividend Companies for NYSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
LOMA Dividend Knight 2023-06-30 Quarterly 2 5.23% 8.53
PHK Dividend Royal 2023-11-10 Monthly 22 6.88% 8.50
JQC Dividend Royal 2023-11-14 Monthly 22 6.56% 8.50
PCF Dividend King 2023-12-18 Monthly 38 7.05% 8.50
PVL Dividend King 2023-11-15 Monthly 14 9.37% 8.50
NCV Dividend Royal 2024-02-09 Monthly 22 7.68% 8.50
SBR Dividend Royal 2023-11-14 Monthly 38 7.74% 8.50
MTR Dividend Diamond 2023-10-30 Monthly 39 10.10% 8.50
PDI Dividend Royal 2023-11-10 Monthly 13 7.86% 8.50
ZTR Dividend King 2024-02-09 Monthly 37 8.35% 8.50

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM01.50000[0 - 0.5]
returnOnAssetsTTM-1.0221.200-10.00-10.00[0 - 0.3]
returnOnEquityTTM-0.9371.500-10.00-10.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM2.530.8002.331.864[1 - 3]
quickRatioTTM2.160.8002.021.617[0.8 - 2.5]
cashRatioTTM0.7371.5007.0210.00[0.2 - 2]
debtRatioTTM0.0703-1.5008.83-10.00[0 - 0.6]
interestCoverageTTM440.771.00010.0010.00[3 - 30]
operatingCashFlowPerShareTTM-1.6992.00-0.566-1.132[0 - 30]
freeCashFlowPerShareTTM-1.7882.00-0.894-1.788[0 - 20]
debtEquityRatioTTM0.102-1.5009.59-10.00[0 - 2.5]
grossProfitMarginTTM01.000-3.33-3.33[0.2 - 0.8]
operatingProfitMarginTTM01.000-2.00-2.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-12.131.000-10.00-10.00[0.2 - 2]
assetTurnoverTTM00.800-3.33-2.67[0.5 - 2]
Total Score0.156

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-2.171.000-0.3210[1 - 100]
returnOnEquityTTM-0.9372.50-7.41-10.00[0.1 - 1.5]
freeCashFlowPerShareTTM-1.7882.00-0.596-1.788[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-1.6992.00-0.566-1.132[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.06241.500-2.920[0.5 - 2]
operatingCashFlowSalesRatioTTM01.000-2.500[0.1 - 0.5]
Total Score-1.952

First Trust Heitman

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. The company was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。